Aug 31 2010

Positive OGX-011 Phase II Results Published in Journal of Clinical Oncology

The results from a Phase II clinical trial of OGX-011, lead by Dr. Kim Chi, have been published in the Journal of Clinical Oncology. OGX-011 was developed at the Vancouver Prostate Centre, and is now moving to Phase III trials.Further details describing the development of OGX-011 were recently the subject of an article in the Vancouver Sun.

Read more
Jun 01 2010

The Centre for Drug Research and Development and Vancouver Prostate Centre Sign a Preferred Collaboration Agreement

Two Vancouver-based “Centres of Excellence in Commercialization in Research” Leverage Resources and Expertise to Develop Anti-Cancer TherapeuticsVANCOUVER, BC – The Centre for Drug Research and Development (CDRD) and the Vancouver Prostate Centre (VPC) today announced that they have signed a preferred collaboration agreement as the two organizations jointly strive to accelerate the discovery, development and commercialization of anti-cancer therapeutics.“Knowing that our two organizations hold similar mandates, this collaboration with CDRD ensures that we are maximizing our resources to inc

Read more
May 20 2010

B.C. Signs Agreement with Japanese Company to Beat Cancer

OSAKA, JPN – The BC Cancer Agency and the Vancouver Protate Centre announced a formal agreement with Japan-based Takeda Pharmaceutical Co. Ltd. for new drug treatments to fight breast, ovarian and prostate cancers.The agreement is expected to bring almost $1 million in new cancer research funding to British Columbia.“We have been able to attract this investment in cancer research to British Columbia because of the unique integration of world-class care and research being done by the BC Cancer Agency and the Vancouver Prostate Centre,” said Premier Gordon Campbell.

Read more
Apr 30 2010

Queensland Government funds international drug discovery alliance

An international project using exotic wildlife to find cures for prostate cancer and other fatal diseases has received major Queensland Government funding.Queensland Premier Anna Bligh has today announced that $1.53 million Smart Futures Fund grant to support a new $6.2 million Queensland-British Columbia Drug Discovery Alliance between Griffith University’s Eskitis Institute, the Australian Prostate Cancer Research Centre, and two British Columbia research centres -- the Centre for Drug Research and Development and the Vancouver Prostate Centre.The breakthrough project’s ultimate goal is t

Read more
Mar 25 2010

Le Vancouver Prostate Centre et Astrazeneca Prolongent Leur Entente de Partenariat de Recherche

VANCOUVER, COLOMBIE-BRITANNIQUE – Le Vancouver Prostate Centre a annoncé la prolongation de son partenariat avec AstraZeneca, ce qui lui permettra de recevoir un montant de 700 000 $ sur deux ans pour financer la recherche sur le cancer de la prostate réfractaire au traitement.L’objectif de cette recherche, dont la coordination est assurée par le Vancouver Prostate Centre, un centre d’excellence quant à la commercialisation et à la recherche, est d’évaluer les petites molécules découvertes par AstraZeneca qui ciblent les récepteurs des androgènes et le cycle de croissance cellulaire, afin d

Read more
Mar 04 2010

Astrazeneca Invests $2.1 million in support of Cancer Resarch in BC

Investment recognizes world class oncology research and development expertise at BC Cancer Agency and Vancouver Prostate Centre.MISSISSAUGA, ONTARIO – AstraZeneca Canada is pleased to announce a $500,000 investment to support oncology research and development at the BC Cancer Agency (BCCA).

Read more
Jan 25 2010

Vancouver Prostate Centre and Astrazeneca Extend Collaborative Research Agreement

VANCOUVER, BRITISH COLUMBIA – The Vancouver Prostate Centre announced today an extended collaboration with AstraZeneca that sees the Vancouver Prostate Centre receive $700,000 over two years towards research that targets treatment-resistant prostate cancer.The research, which is being coordinated through the Vancouver Prostate Centre ― a Centre of Excellence for Commercialization and Research ― evaluates AstraZeneca's androgen receptor-targeting small molecules, as well as, molecules that target cell cycle growth to slow, or stop, tumour proliferation in prostate cancer.Specifically this re

Read more
Dec 03 2009

Pfizer and B.C. Launch $9m Collaboration to Tackle Cancer

VANCOUVER – Pfizer is entering into a three-year, $9-million research collaboration with the BC Cancer Agency and the Vancouver Prostate Centre, a University of British Columbia (UBC) and Vancouver General Hospital (VGH) Centre of Excellence, to tackle new treatment avenues for breast, ovarian and prostate cancer.

Read more



Jul 26 2017

Dr. Zoubeidi awarded PCC-Movember Translation Acceleration Grant

July 26, 2017 - TORONTO, ON - Continuing their longstanding tradition of partnering to fund high quality Canadian prostate cancer research, Prostate Cancer Canada (PCC) and The Movember Foundation today announced two new projects with very real potential to make a tangible difference in the lives of men living with aggressive forms of prostate cancer.

Read more